vs

Side-by-side financial comparison of Prelude Therapeutics Inc (PRLD) and NUSCALE POWER Corp (SMR). Click either name above to swap in a different company.

NUSCALE POWER Corp is the larger business by last-quarter revenue ($8.2M vs $6.5M, roughly 1.3× Prelude Therapeutics Inc). Prelude Therapeutics Inc runs the higher net margin — -303.5% vs -3316.2%, a 3012.7% gap on every dollar of revenue. On growth, NUSCALE POWER Corp posted the faster year-over-year revenue change (1635.2% vs 116.7%).

NuScale Power Corporation is a publicly traded American company that designs and markets small modular reactors (SMRs). It is headquartered in Tigard, Oregon. The company's VOYGR power plant, which uses 50 MWe modules and scales to 12 modules, was the first SMR to be certified by the US Nuclear Regulatory Commission (NRC) (2022). The newer 77 MWe module designs, known as the VOYGR-4 and VOYGR-6, were submitted for NRC review on January 1, 2023, and approved May 29, 2025. NuScale is now seekin...

PRLD vs SMR — Head-to-Head

Bigger by revenue
SMR
SMR
1.3× larger
SMR
$8.2M
$6.5M
PRLD
Growing faster (revenue YoY)
SMR
SMR
+1518.5% gap
SMR
1635.2%
116.7%
PRLD
Higher net margin
PRLD
PRLD
3012.7% more per $
PRLD
-303.5%
-3316.2%
SMR

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
PRLD
PRLD
SMR
SMR
Revenue
$6.5M
$8.2M
Net Profit
$-19.7M
$-273.3M
Gross Margin
32.9%
Operating Margin
-314.1%
-6532.9%
Net Margin
-303.5%
-3316.2%
Revenue YoY
116.7%
1635.2%
Net Profit YoY
38.9%
-1465.5%
EPS (diluted)
$-0.26
$-1.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRLD
PRLD
SMR
SMR
Q3 25
$6.5M
$8.2M
Q2 25
$8.1M
Q1 25
$13.4M
Q4 24
$34.2M
Q3 24
$3.0M
Q4 23
$4.6M
Q3 23
$7.0M
Q2 23
$5.8M
Net Profit
PRLD
PRLD
SMR
SMR
Q3 25
$-19.7M
$-273.3M
Q2 25
$-17.6M
Q1 25
$-14.0M
Q4 24
$-75.0M
Q3 24
$-32.3M
Q4 23
$-18.8M
Q3 23
$-19.1M
Q2 23
$-9.5M
Gross Margin
PRLD
PRLD
SMR
SMR
Q3 25
32.9%
Q2 25
22.1%
Q1 25
52.4%
Q4 24
91.1%
Q3 24
Q4 23
15.8%
Q3 23
14.5%
Q2 23
0.5%
Operating Margin
PRLD
PRLD
SMR
SMR
Q3 25
-314.1%
-6532.9%
Q2 25
-534.9%
Q1 25
-264.1%
Q4 24
-34.6%
Q3 24
-1145.9%
Q4 23
-1558.2%
Q3 23
-1336.9%
Q2 23
-968.4%
Net Margin
PRLD
PRLD
SMR
SMR
Q3 25
-303.5%
-3316.2%
Q2 25
-219.0%
Q1 25
-104.7%
Q4 24
-219.1%
Q3 24
-1075.7%
Q4 23
-411.3%
Q3 23
-275.1%
Q2 23
-164.3%
EPS (diluted)
PRLD
PRLD
SMR
SMR
Q3 25
$-0.26
$-1.85
Q2 25
$-0.13
Q1 25
$-0.11
Q4 24
$-0.77
Q3 24
$-0.43
Q4 23
$-0.25
Q3 23
$-0.26
Q2 23
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRLD
PRLD
SMR
SMR
Cash + ST InvestmentsLiquidity on hand
$55.0M
$691.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$58.5M
$828.7M
Total Assets
$94.8M
$883.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRLD
PRLD
SMR
SMR
Q3 25
$55.0M
$691.8M
Q2 25
$420.7M
Q1 25
$521.4M
Q4 24
$441.6M
Q3 24
$153.6M
Q4 23
$120.3M
Q3 23
$117.5M
Q2 23
$154.4M
Stockholders' Equity
PRLD
PRLD
SMR
SMR
Q3 25
$58.5M
$828.7M
Q2 25
$692.9M
Q1 25
$704.0M
Q4 24
$618.7M
Q3 24
$156.4M
Q4 23
$93.5M
Q3 23
$105.9M
Q2 23
$110.1M
Total Assets
PRLD
PRLD
SMR
SMR
Q3 25
$94.8M
$883.1M
Q2 25
$606.5M
Q1 25
$618.1M
Q4 24
$544.7M
Q3 24
$197.2M
Q4 23
$224.9M
Q3 23
$308.5M
Q2 23
$309.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRLD
PRLD
SMR
SMR
Operating Cash FlowLast quarter
$-19.1M
$-199.8M
Free Cash FlowOCF − Capex
$-199.9M
FCF MarginFCF / Revenue
-2425.1%
Capex IntensityCapex / Revenue
0.0%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRLD
PRLD
SMR
SMR
Q3 25
$-19.1M
$-199.8M
Q2 25
$-33.3M
Q1 25
$-22.8M
Q4 24
$-26.4M
Q3 24
$-27.3M
Q4 23
$-73.2M
Q3 23
$-27.7M
Q2 23
$-39.2M
Free Cash Flow
PRLD
PRLD
SMR
SMR
Q3 25
$-199.9M
Q2 25
Q1 25
$-22.9M
Q4 24
$-26.5M
Q3 24
$-27.4M
Q4 23
$-73.3M
Q3 23
$-27.7M
Q2 23
$-40.5M
FCF Margin
PRLD
PRLD
SMR
SMR
Q3 25
-2425.1%
Q2 25
Q1 25
-170.9%
Q4 24
-77.3%
Q3 24
-912.0%
Q4 23
-1606.6%
Q3 23
-399.0%
Q2 23
-698.9%
Capex Intensity
PRLD
PRLD
SMR
SMR
Q3 25
0.0%
0.9%
Q2 25
Q1 25
0.5%
Q4 24
0.1%
Q3 24
2.1%
Q4 23
1.1%
Q3 23
0.8%
Q2 23
21.9%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRLD
PRLD

Segment breakdown not available.

SMR
SMR

Power Plant And NPM Engineering Design And Licensing Services And Fees$8.0M97%
Other$208.0K3%

Related Comparisons